Check out the latest antibody-drug conjugate news. This section covers the latest updates on approvals, regulations, deals, and antibody–drug conjugate (ADC) technology.
News and Trends 14 Mar 2023
Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline
Pfizer Inc. is set to acquire Seagen Inc. for $229 in cash per Seagen share for a total enterprise value…